Advance mRNA Vaccine Development, Scale-up and Manufacturing

28 Apr, 2022 | Newsletters
Advance mRNA Vaccine Development, Scale-up and Manufacturing
Creating a genetic ecosystem – Part 3 This pandemic is far from over as variants continue to emerge. Vaccines are amazing, yet not perfect. Take a look at our latest article where we discuss the current delivery of funding and the plan forward for a genetic medicine ecosystem.
Changing the Status Quo of Vaccine Production
Learn how the mRNA technology behind COVID-19 vaccines is poised to disrupt the status quo to improve manufacturing capabilities.

Read More

Translation of RNA Medicines from Design to Clinic
Understand the advantages and challenges of lipid-based delivery systems for successful translation of RNA into clinical development.
Read More
How Tools and Technologies Bring Advanced Therapies to Market 
Gain insight into the latest manufacturing technologies and tools to support the development of RNA vaccines and therapeutics.

Read More 

Accelerating The Development And Scale-Up Of mRNA Vaccines
Learn how downstream considerations can make the difference between success and failure on the path towards the commercialisation of mRNA vaccines.

Read more  
Request a personal demo Request a quote now Email us for more info